13d
Everyday Health on MSNCommon MS Drug Causes Rare but Potentially Deadly Allergic Reactions, FDA WarnsThe FDA noted that 82 people taking these glatiramer acetate medications required ER visits or hospitalizations, and 6 others ...
Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...
ALBANY — An investigation into a series of episodes in which state prison workers have been rushed to hospitals after ...
Alpha-gal syndrome was discovered because of unexpected severe drug reactions, including anaphylaxis, in some patients who took cetuximab, a cancer drug. A 2008 study found antibodies to alpha-gal ...
The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use of multiple sclerosis drugs including Teva's Copaxone. The health ...
Jan 22 (Reuters) - The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use of some multiple sclerosis drugs including Teva's ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
New Boxed Warning added to highlight the risk of severe allergic reactions at any stage of treatment. Brand New Membership Level: Benzinga Trade Alerts The U.S. Food and Drug Administration (FDA ...
Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...
An Illinois lawmaker is pushing a new bill that would ensure parents have the final say before their kids are prescribed psychotropic medications.
Adverse drug reactions (ADRs) remain a common clinical problem since they can mimic many diseases and cause significant morbidity and mortality. Judicious prescribing is important to minimize ...
GLP1 receptor agonists are widely prescribed to help control blood sugar levels and support weight loss. While these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results